Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0149 USD
−1.82 M USD
69.79 K USD
106.83 M
About Appili Therapeutics Inc Class A
Sector
Industry
CEO
Don Cilla
Website
Headquarters
Halifax
Founded
2015
ISIN
CA03783R1073
FIGI
BBG00TZ8G3G9
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APLIF is 0.0200 USD — it has increased by 35.14% in the past 24 hours. Watch Appili Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Appili Therapeutics Inc. stocks are traded under the ticker APLIF.
APLIF stock has risen by 16.96% compared to the previous week, the month change is a 23.92% rise, over the last year Appili Therapeutics Inc. has showed a −17.70% decrease.
APLIF reached its all-time high on May 20, 2020 with the price of 1.3681 USD, and its all-time low was 0.0089 USD and was reached on Jul 1, 2025. View more price dynamics on APLIF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APLIF stock is 26.00% volatile and has beta coefficient of 1.99. Track Appili Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Appili Therapeutics Inc. there?
Today Appili Therapeutics Inc. has the market capitalization of 2.17 M, it has increased by 0.92% over the last week.
Yes, you can track Appili Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Appili Therapeutics Inc. is going to release the next earnings report on Feb 17, 2026. Keep track of upcoming events with our Earnings Calendar.
APLIF net income for the last quarter is −710.15 K USD, while the quarter before that showed −917.82 K USD of net income which accounts for 22.63% change. Track more Appili Therapeutics Inc. financial stats to get the full picture.
No, APLIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 5, 2025, the company has 7 employees. See our rating of the largest employees — is Appili Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Appili Therapeutics Inc. EBITDA is −5.37 M USD, and current EBITDA margin is −9.69 K%. See more stats in Appili Therapeutics Inc. financial statements.
Like other stocks, APLIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Appili Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Appili Therapeutics Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Appili Therapeutics Inc. stock shows the neutral signal. See more of Appili Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.